CPH Group's Perlen Packaging to Acquire LOG Pharma

CPH Group's Perlen Packaging division plans to acquire LOG Pharma, with production sites in Israel and Hungary. The acquisition, announced on December 4, 2024, aims to complete by the first quarter of fiscal year 2025. LOG Pharma specializes in packaging with high barrier properties, ensuring safe solutions for pharmaceutical products. In 2023, it reported revenues of CHF 26 million and EBITDA of CHF 2.7 million.

The acquisition reflects Perlen Packaging's strategy to expand and strengthen its market position in pharmaceutical packaging. By entering the Eastern European market, particularly in Hungary, CPH aims to exploit market synergies and enhance capabilities. This move aligns with CPH's focus on niche markets with growth potential.

Following its strategic spin-off of Perlen Paper in 2024, CPH continues to focus on growth in its Packaging and Chemistry divisions, with a promising long-term outlook and anticipated margin improvements leading to solid earnings growth.